title: Effect of daptomycin on primary rat muscle cell cultures in vitro.
abstract: Daptomycin is a lipopeptide antibiotic that has strong bactericidal activity against Gram-positive bacteria and that was previously reported to exhibit minor side effects on skeletal muscle. This study was designed to further characterize the effect of daptomycin on skeletal muscle through the use of primary cultures of muscles from rats. Our investigations demonstrated that daptomycin has a concentration-dependent and time-dependent effect on the plasma membrane of primary cultures of differentiated, spontaneously contracting rat myotubes. No effects were evident in non-differentiated myoblasts or other mononucleated cells present in cultures even at the highest daptomycin concentrations tested (6,000 microg/mL). In cultures treated with daptomycin at a concentration of 2,000 microg/mL, plasma membrane damage was observed in approximately 20-30% of differentiated myotubes; no myotube damage was detected at concentrations of 1,000 microg/mL and below. A transient loss of spontaneous myotube contractions was evident at 750 microg/mL, while at 2,000 microg/mL and above, a permanent loss of spontaneous contractility was observed. These results suggest that the putative targets for daptomycin effects on skeletal muscle are structures on the plasma membrane of highly differentiated myotubes.
authors.affiliation: Department of Molecular and Integrative Physiology, BSRB, University of Michigan, Ann Arbor, MI 48109-2200, USA. tkostrom@iun.edu
authors.forename: Tatiana Y
authors.initials: TY
authors.lastname: Kostrominova
authors.forename: Scott
authors.initials: S
authors.lastname: Coleman
authors.forename: Frederick B
authors.initials: FB
authors.lastname: Oleson
authors.forename: John A
authors.initials: JA
authors.lastname: Faulkner
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Larkin
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002478:Cells, Cultured; D017576:Daptomycin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005455:Fluorescent Antibody Technique; D032342:Muscle Cells / Q000166:cytology* / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D018485:Muscle Fibers, Skeletal / Q000166:cytology / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D017576:Daptomycin
references.citation: Front Biosci. 2006 Sep 01;11:3036-48
references.pmid: 16720374
references.citation: Fundam Appl Toxicol. 1987 Jul;9(1):10-7
references.pmid: 3622955
references.citation: Antimicrob Agents Chemother. 2000 Nov;44(11):2948-53
references.pmid: 11036005
references.citation: Antimicrob Agents Chemother. 1990 Jun;34(6):1220-6
references.pmid: 2168145
references.citation: Plast Reconstr Surg. 1991 May;87(5):917-24
references.pmid: 2017501
references.citation: Toxicol Appl Pharmacol. 1992 Dec;117(2):194-9
references.pmid: 1471151
references.citation: Tissue Eng. 2006 Nov;12(11):3149-58
references.pmid: 17518629
references.citation: J Antimicrob Chemother. 2005 Mar;55(3):283-8
references.pmid: 15705644
references.citation: In Vitro Cell Dev Biol. 1990 Apr;26(4):393-8
references.pmid: 2345125
references.citation: FASEB J. 2004 Feb;18(2):403-5
references.pmid: 14688207
references.citation: Clin Microbiol Infect. 2006 Mar;12 Suppl 1:24-32
references.pmid: 16445721
references.citation: Toxicol In Vitro. 2002 Apr;16(2):193-200
references.pmid: 11869882
references.citation: J Muscle Res Cell Motil. 2006;27(1):75-81
references.pmid: 16538437
references.citation: Antimicrob Agents Chemother. 2003 Aug;47(8):2538-44
references.pmid: 12878516
references.citation: Toxicol In Vitro. 2007 Oct;21(7):1348-53
references.pmid: 17596909